• LAST PRICE
    59.7356
  • TODAY'S CHANGE (%)
    Trending Down-1.3544 (-2.2171%)
  • Bid / Lots
    59.6900/ 7
  • Ask / Lots
    59.7700/ 3
  • Open / Previous Close
    61.0800 / 61.0900
  • Day Range
    Low 59.5205
    High 62.0200
  • 52 Week Range
    Low 33.1500
    High 65.5327
  • Volume
    683,105
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 61.09
TimeVolumeHALO
09:32 ET1455261.28
09:33 ET246861.05
09:35 ET240060.985
09:37 ET205861.36
09:39 ET200061.52
09:42 ET181161.42
09:44 ET225161.66
09:46 ET469161.55
09:48 ET440561.73
09:50 ET379961.76
09:51 ET501161.98
09:53 ET482961.86
09:55 ET488961.71
09:57 ET111161.76
10:00 ET445761.69
10:02 ET122761.79
10:04 ET143461.92
10:06 ET406561.8
10:08 ET150061.92
10:09 ET705461.85
10:11 ET1067361.8525
10:13 ET4689161.91
10:15 ET420761.725
10:18 ET2557161.81
10:20 ET326461.605
10:22 ET2327161.445
10:24 ET512861.39
10:26 ET256261.22
10:27 ET40061.23
10:29 ET283561.19
10:31 ET206061.195
10:33 ET269361.18
10:36 ET283261.285
10:38 ET532361.13
10:40 ET260061.065
10:42 ET546861.0221
10:44 ET201060.92
10:45 ET935060.77
10:47 ET245260.78
10:49 ET397760.685
10:51 ET347060.67
10:54 ET1111260.78
10:56 ET348160.82
10:58 ET568660.755
11:00 ET242060.7
11:02 ET90060.665
11:03 ET368860.84
11:05 ET252160.872
11:07 ET310760.74
11:09 ET162560.715
11:12 ET213760.61
11:14 ET219460.695
11:16 ET309660.76
11:18 ET120060.7349
11:20 ET316360.695
11:21 ET267960.86
11:23 ET548960.8
11:25 ET228460.8
11:27 ET352460.825
11:30 ET90060.79
11:32 ET456060.765
11:34 ET332060.815
11:36 ET250060.875
11:38 ET1072460.875
11:39 ET298260.845
11:41 ET165260.86
11:43 ET197060.825
11:45 ET100060.76
11:48 ET224560.65
11:50 ET60060.685
11:52 ET197560.665
11:54 ET235760.755
11:56 ET237660.8
11:57 ET190060.66
11:59 ET201860.525
12:01 ET150060.5
12:03 ET278060.47
12:06 ET126160.485
12:08 ET180360.41
12:10 ET200060.355
12:12 ET127560.38
12:14 ET353660.32
12:15 ET275060.3
12:17 ET215060.215
12:19 ET146060.15
12:21 ET371060.11
12:24 ET336060.11
12:26 ET394460.15
12:28 ET130060.235
12:30 ET142860.28
12:32 ET273160.36
12:33 ET56060.35
12:35 ET240060.3
12:37 ET90060.2
12:39 ET274360.15
12:42 ET945159.84
12:44 ET254659.755
12:46 ET669259.795
12:48 ET310059.77
12:50 ET416459.68
12:51 ET732859.57
12:53 ET220059.58
12:55 ET322459.74
12:57 ET482759.8
01:00 ET203559.705
01:02 ET149659.73
01:04 ET403259.755
01:06 ET280059.705
01:08 ET160059.73
01:09 ET347659.805
01:11 ET506659.835
01:13 ET110059.735
01:15 ET203259.805
01:18 ET43959.84
01:20 ET140059.83
01:22 ET228859.975
01:24 ET155059.895
01:26 ET117459.895
01:27 ET52759.96
01:29 ET87059.97
01:31 ET360660.025
01:33 ET210960.03
01:36 ET174659.98
01:38 ET4185160.0932
01:40 ET226159.92
01:42 ET30059.86
01:44 ET100059.79
01:45 ET10059.735596
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesHALO
Halozyme Therapeutics Inc
7.8B
19.8x
---
United StatesSUPN
Supernus Pharmaceuticals Inc
2.0B
35.2x
-59.02%
United StatesPAHC
Phibro Animal Health Corp
1.0B
59.5x
-46.35%
United StatesEGRX
Eagle Pharmaceuticals Inc
11.0M
0.8x
-4.75%
United StatesELTP
Elite Pharmaceuticals Inc
577.9M
28.8x
---
United StatesSGTI
Shengtai Pharmaceutical Inc
10.0
0.0x
---
As of 2024-11-12

Company Information

Halozyme Therapeutics, Inc. is a biopharmaceutical company advancing disruptive solutions to improve patient experiences and outcomes for emerging and established therapies. The Company’s ENHANZE drug delivery technology with the proprietary enzyme rHuPH20, its commercially validated solution is used to facilitate the subcutaneous (SC) delivery of injected drugs and fluids, with a focus on reducing treatment burden for patients. It also develops, manufactures, and commercializes, for itself or with partners, drug-device combination products using its advanced auto-injector technologies. The Company has two commercial proprietary products, Hylenex and XYOSTED, partnered commercial products and ongoing product development programs with several pharmaceutical companies. It markets and sells Hylenex recombinant, which is a formulation of rHuPH20. It markets and sells its proprietary product XYOSTED for SC administration of testosterone replacement therapy (TRT) in adult males.

Contact Information

Headquarters
12390 EL CAMINO REALSAN DIEGO, CA, United States 92130
Phone
858-794-8889
Fax
302-655-5049

Executives

Independent Chairman of the Board
Jeffrey Henderson
President, Chief Executive Officer, Director
Helen Torley
Chief Financial Officer, Senior Vice President
Nicole Labrosse
Senior Vice President, Chief Technical Officer
Michael Labarre
Senior Vice President, Chief Compliance Officer, General Counsel, Secretary
Mark Snyder

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$7.8B
Revenue (TTM)
$947.4M
Shares Outstanding
127.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.29
EPS
$3.02
Book Value
$0.66
P/E Ratio
19.8x
Price/Sales (TTM)
8.2
Price/Cash Flow (TTM)
16.4x
Operating Margin
50.35%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.